61 results
Page 3 of 4
8-K
EX-1.1
6dl2o6oqhs6odo4ds
17 Dec 20
Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program
7:05am
DEFA14A
vxlct2xdlk pgksbjo
28 May 20
Additional proxy soliciting materials
4:00pm
8-K
EX-1.1
e68h7yxr4m8 473e
22 May 20
Entry into a Material Definitive Agreement
4:14pm
DEFA14A
od6j45cg5 adkb05gobx
22 Apr 20
Additional proxy soliciting materials
6:08am
8-K
EX-10.1
u9uins02h nhu
25 Nov 19
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
8:07am
S-3
EX-1.2
nle7ii9i3lxd3s5wcb
1 May 19
Shelf registration
8:02am
S-3
EX-4.3
g4p93xhh3x3nu4okwo4
1 May 19
Shelf registration
8:02am
S-3
EX-4.2
q2r919txn9ppi9mzk4
1 May 19
Shelf registration
8:02am
DEFA14A
sfs9rotp83rs 5q
19 Apr 19
Additional proxy soliciting materials
6:07am
DEF 14A
vxtlkep4nlw0l5o
19 Apr 19
Definitive proxy
6:04am
10-K
ukjyv 7b9
7 Mar 19
Annual report
4:13pm
10-Q
asn5i jcn1i1arx
29 May 18
Quarterly report
5:11pm
8-K
EX-10.1
pbprw6k73a6r1q
24 May 18
Entry into a Material Definitive Agreement
4:27pm